Eugene Major
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Eugene (Gene) O. Major, PhD, is a senior investigator at the National Institute of Neurological Disorders and Stroke (NINDS), a division of the United States National Institutes of Health (NIH).
He has a research interest in progressive multifocal leukoencephalopathy (PML), a rare and usually fatal viral disease caused by a weakened immune system, an occurrence that could follow treatment with Rituximab.
Dr Major is one of the Associate Investigators assigned to the NIH Post-Infectious ME/CFS Study.[1]
Notable studies[edit | edit source]
- 2009, Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project[2] (Full text)
- 2010, Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies[3]
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
Learn more[edit | edit source]
- Wikipedia - Eugene O Major
- Institution
See also[edit | edit source]
References[edit | edit source]
- ↑ https://www.cdc.gov/cdcgrandrounds/pdf/archives/2016/feb2016.pdf
- ↑ Carson, K. R., Evens, A.M., Richey, E. A., Habermann, T. M., Focosi,D., Seymour, J. F., … Bennett, C. L. (2009). Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood, 113(20), 4834–4840. http://doi.org/10.1182/blood-2008-10-186999
- ↑ Major EO. (2010). Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies. Annu Rev Med. 2010;61:35-47. doi: 10.1146/annurev.med.080708.082655.
